Home » Topics » Regulatory » Patents

Patents
RSS

Allergan continues research into retinoids and retinoid-like compounds

Feb. 3, 1997

Potent antitumor agents from Takeda

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Shaman describes antidiabetic agents from natural source

Jan. 31, 1997

DuPont Merck reports new fibrinogen antagonists

Jan. 31, 1997

CP-0840: Dual-action bradykinin antagonist/mu-opioid agonist from Cortech

Jan. 31, 1997

New anticoagulant drug candidates from Berlex

Jan. 31, 1997

New MMP inhibitors reported by Warner-Lambert

Jan. 31, 1997

Takeda researches follow-up compounds to leuprorelin

Jan. 31, 1997

Astra investigates H. pylori vaccines

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.